2 completed, 2 terminated. 3 Phase 3, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Not applicable | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow sarizotan: new trials by email Literature Review of sarizotan trials Research Report on sarizotan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms Sarizotan low dose, Sarizotan high dose, Placebo - Rett Syndrome | Phase 2 / Phase 3 | Terminated | Newron Pharmaceuticals SPA | 129 | 2016-10-26 | 2021-12-21 |
| Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia Sarizotan, Placebo - Neuroleptic-induced Tardive Dyskinesia | Not applicable | Terminated | Centre for Addiction and Mental Health | 60 | 2004-12-01 | 2015-07-23 |
| Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia Sarizotan, Placebo - Parkinson's Disease, Dyskinesia | Phase 3 | Completed | EMD Serono | 506 | 2004-09-30 | 2018-07-26 |
| Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia Sarizotan, Placebo - Parkinson's Disease, Dyskinesia | Phase 3 | Completed | EMD Serono | 398 | 2004-09-30 | 2018-04-02 |
Dyskinesias (2) · Parkinson Disease (2) · Rett Syndrome (1)
EMD Serono (2) · Centre for Addiction and Mental Health (1) · Newron Pharmaceuticals SPA (1)
United States (3) · India (2) · Australia (1) · Canada (1) · Italy (1) · United Kingdom (1)
Gary Remington, MD (1) · Ravi Anand, MD (1)